Daz, recent examples of by where following the release of their respective PFS for Battery leveraged stocks such as LTR and CXO have seen 15 x and 6 X increase in share price. Admittedly they have also since announced company making offtake partners and both CEO'S are very much front and centre selling the story. Regularly updating shareholders, newsflow for both is almost on a weekly basis.
What will happen following the release of the Scoping study largely depends on the level of detail within the document. If we are going to be a lowest or even a low cost producer then let's hear it and how. ie. what are the expected costs of production. I'm off the belief that margins here could be in the vacinity of $2,000.00 a ton but again the market needs to hear it from JB.
When we get the operational announcement acknowledging operations have commenced and plant optimised, that will largely improve sentiment and lead to a nice headway for the scoping study to be released. Thus we should have two significant announcements made before Christmas.
- Forums
- ASX - By Stock
- E25
- Scoping Study
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Scoping Study, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
3 | 28857 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online